| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anemia, Sideroblastic | 21 | 2022 | 101 | 7.440 |
Why?
|
| Genetic Diseases, X-Linked | 13 | 2021 | 372 | 4.320 |
Why?
|
| Iron | 49 | 2022 | 1774 | 4.230 |
Why?
|
| beta-Thalassemia | 10 | 2020 | 225 | 2.710 |
Why?
|
| Antimicrobial Cationic Peptides | 15 | 2013 | 362 | 2.580 |
Why?
|
| Anemia, Iron-Deficiency | 13 | 2021 | 365 | 2.570 |
Why?
|
| Erythropoiesis | 23 | 2020 | 705 | 2.340 |
Why?
|
| Iron Overload | 16 | 2018 | 243 | 2.290 |
Why?
|
| Membrane Proteins | 27 | 2020 | 7879 | 1.830 |
Why?
|
| Hemochromatosis | 12 | 2020 | 184 | 1.800 |
Why?
|
| Receptors, Transferrin | 7 | 2020 | 296 | 1.730 |
Why?
|
| Cation Transport Proteins | 14 | 2022 | 327 | 1.670 |
Why?
|
| Serine Endopeptidases | 8 | 2020 | 1073 | 1.670 |
Why?
|
| 5-Aminolevulinate Synthetase | 4 | 2021 | 57 | 1.600 |
Why?
|
| Mitochondrial Proteins | 6 | 2018 | 996 | 1.520 |
Why?
|
| Transferrin | 11 | 2016 | 295 | 1.480 |
Why?
|
| Protoporphyria, Erythropoietic | 5 | 2022 | 43 | 1.470 |
Why?
|
| Heme | 11 | 2015 | 307 | 1.360 |
Why?
|
| Placenta | 4 | 2022 | 1697 | 1.160 |
Why?
|
| Anemia | 16 | 2019 | 1504 | 1.130 |
Why?
|
| Mutation, Missense | 11 | 2020 | 2563 | 1.070 |
Why?
|
| Mutation | 43 | 2023 | 29784 | 1.030 |
Why?
|
| Erythroid Precursor Cells | 9 | 2018 | 218 | 0.990 |
Why?
|
| Anemia, Hypochromic | 5 | 2017 | 66 | 0.900 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 3 | 2021 | 154 | 0.830 |
Why?
|
| Germ-Line Mutation | 5 | 2021 | 1787 | 0.800 |
Why?
|
| Erythrocytes | 12 | 2017 | 2454 | 0.770 |
Why?
|
| MELAS Syndrome | 2 | 2018 | 50 | 0.770 |
Why?
|
| DNA, Mitochondrial | 4 | 2023 | 817 | 0.760 |
Why?
|
| Receptors, Virus | 2 | 2015 | 648 | 0.740 |
Why?
|
| Jews | 1 | 2022 | 385 | 0.740 |
Why?
|
| Mesenteric Artery, Inferior | 1 | 2020 | 15 | 0.730 |
Why?
|
| Membrane Transport Proteins | 5 | 2015 | 1028 | 0.720 |
Why?
|
| Histocompatibility Antigens Class I | 7 | 2014 | 1366 | 0.690 |
Why?
|
| RNA Interference | 4 | 2018 | 2890 | 0.680 |
Why?
|
| Replantation | 1 | 2020 | 148 | 0.660 |
Why?
|
| Tyrosine-tRNA Ligase | 1 | 2018 | 10 | 0.660 |
Why?
|
| Mice | 87 | 2024 | 81178 | 0.650 |
Why?
|
| Iron-Binding Proteins | 7 | 2001 | 79 | 0.640 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2018 | 52 | 0.640 |
Why?
|
| Medical Assistance | 1 | 2018 | 104 | 0.640 |
Why?
|
| Mice, Mutant Strains | 19 | 2019 | 1866 | 0.620 |
Why?
|
| Splenectomy | 3 | 2018 | 395 | 0.610 |
Why?
|
| Myelodysplastic Syndromes | 9 | 2023 | 1352 | 0.610 |
Why?
|
| Germinal Center | 1 | 2020 | 377 | 0.600 |
Why?
|
| Animals | 113 | 2024 | 168788 | 0.590 |
Why?
|
| Hematopoiesis | 6 | 2019 | 2069 | 0.590 |
Why?
|
| Phenotype | 22 | 2021 | 16365 | 0.580 |
Why?
|
| Acidosis, Lactic | 1 | 2018 | 142 | 0.580 |
Why?
|
| Immunologic Deficiency Syndromes | 4 | 2015 | 547 | 0.570 |
Why?
|
| Bone Marrow Diseases | 5 | 2022 | 230 | 0.570 |
Why?
|
| Chromosomes, Human, X | 2 | 2016 | 296 | 0.560 |
Why?
|
| Sequence Deletion | 6 | 2016 | 1526 | 0.560 |
Why?
|
| Oxidoreductases | 7 | 2015 | 424 | 0.550 |
Why?
|
| Electron Transport Complex I | 1 | 2016 | 140 | 0.520 |
Why?
|
| Intracellular Fluid | 1 | 2015 | 203 | 0.510 |
Why?
|
| Mitochondrial Diseases | 4 | 2023 | 321 | 0.510 |
Why?
|
| Safety Management | 3 | 2012 | 782 | 0.500 |
Why?
|
| RNA Nucleotidyltransferases | 1 | 2014 | 64 | 0.500 |
Why?
|
| Genotype | 11 | 2021 | 12956 | 0.490 |
Why?
|
| Disease Models, Animal | 17 | 2020 | 18027 | 0.490 |
Why?
|
| Iron Chelating Agents | 1 | 2015 | 139 | 0.480 |
Why?
|
| GATA Transcription Factors | 1 | 2013 | 30 | 0.470 |
Why?
|
| GPI-Linked Proteins | 7 | 2020 | 434 | 0.460 |
Why?
|
| Hair | 2 | 2007 | 483 | 0.460 |
Why?
|
| ATP-Binding Cassette Transporters | 3 | 2010 | 560 | 0.460 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2008 | 1213 | 0.460 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2015 | 404 | 0.450 |
Why?
|
| Homeostasis | 9 | 2019 | 3339 | 0.450 |
Why?
|
| Quantitative Trait Loci | 5 | 2013 | 2019 | 0.440 |
Why?
|
| Base Sequence | 10 | 2016 | 12801 | 0.440 |
Why?
|
| Histiocytosis, Langerhans-Cell | 4 | 2012 | 171 | 0.440 |
Why?
|
| Mice, Inbred C57BL | 32 | 2021 | 21824 | 0.430 |
Why?
|
| FMN Reductase | 4 | 2008 | 13 | 0.420 |
Why?
|
| Proteins | 7 | 2019 | 6101 | 0.420 |
Why?
|
| Medical Errors | 3 | 2012 | 1297 | 0.420 |
Why?
|
| Cell Differentiation | 12 | 2024 | 11478 | 0.410 |
Why?
|
| Iron-Sulfur Proteins | 3 | 2020 | 82 | 0.410 |
Why?
|
| Proteome | 2 | 2021 | 1798 | 0.410 |
Why?
|
| Mice, Knockout | 28 | 2021 | 14556 | 0.400 |
Why?
|
| Colon | 1 | 2020 | 1772 | 0.400 |
Why?
|
| Alleles | 7 | 2014 | 6938 | 0.390 |
Why?
|
| Introns | 2 | 2013 | 991 | 0.390 |
Why?
|
| Apoferritins | 1 | 2010 | 18 | 0.390 |
Why?
|
| Patient Participation | 1 | 2020 | 1457 | 0.390 |
Why?
|
| Health Care Reform | 1 | 2020 | 1261 | 0.380 |
Why?
|
| Anemia, Aplastic | 3 | 2020 | 226 | 0.380 |
Why?
|
| Vascular Surgical Procedures | 1 | 2020 | 1475 | 0.380 |
Why?
|
| Lymph Nodes | 2 | 2020 | 3469 | 0.380 |
Why?
|
| Administrative Personnel | 1 | 2012 | 187 | 0.370 |
Why?
|
| Humans | 147 | 2024 | 744220 | 0.370 |
Why?
|
| Female | 87 | 2022 | 380197 | 0.370 |
Why?
|
| Iron Regulatory Protein 1 | 4 | 2014 | 36 | 0.370 |
Why?
|
| Pyridones | 1 | 2015 | 712 | 0.370 |
Why?
|
| Mitochondria | 8 | 2023 | 3520 | 0.360 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2020 | 1186 | 0.360 |
Why?
|
| DNA Mutational Analysis | 9 | 2020 | 4188 | 0.360 |
Why?
|
| GATA1 Transcription Factor | 4 | 2020 | 293 | 0.360 |
Why?
|
| Reticulocytes | 3 | 2017 | 290 | 0.350 |
Why?
|
| Sperm Tail | 2 | 2011 | 18 | 0.340 |
Why?
|
| Centrosome | 1 | 2010 | 201 | 0.340 |
Why?
|
| Lipid Metabolism, Inborn Errors | 3 | 2022 | 120 | 0.340 |
Why?
|
| Thrombocytopenia | 3 | 2018 | 1175 | 0.330 |
Why?
|
| Exocrine Pancreatic Insufficiency | 2 | 2022 | 80 | 0.330 |
Why?
|
| Leukemia, Myelomonocytic, Juvenile | 1 | 2008 | 20 | 0.330 |
Why?
|
| Chromosome Segregation | 1 | 2010 | 236 | 0.330 |
Why?
|
| Developmental Disabilities | 2 | 2014 | 1456 | 0.330 |
Why?
|
| Carrier Proteins | 11 | 2013 | 5021 | 0.330 |
Why?
|
| Leukemia, Experimental | 1 | 2008 | 246 | 0.320 |
Why?
|
| Copper | 2 | 2013 | 366 | 0.320 |
Why?
|
| Male | 78 | 2022 | 350027 | 0.320 |
Why?
|
| Amino Acid Substitution | 6 | 2020 | 1792 | 0.320 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2010 | 407 | 0.320 |
Why?
|
| Pedigree | 9 | 2020 | 4648 | 0.310 |
Why?
|
| Langerhans Cells | 2 | 2012 | 173 | 0.310 |
Why?
|
| Molecular Sequence Data | 20 | 2015 | 18116 | 0.310 |
Why?
|
| Kartagener Syndrome | 1 | 2007 | 32 | 0.310 |
Why?
|
| Truth Disclosure | 1 | 2012 | 436 | 0.310 |
Why?
|
| Antigens, Neoplasm | 2 | 2006 | 1987 | 0.310 |
Why?
|
| Medical Staff, Hospital | 1 | 2012 | 603 | 0.300 |
Why?
|
| Erythroblasts | 4 | 2020 | 150 | 0.300 |
Why?
|
| Equipment Failure Analysis | 1 | 2010 | 868 | 0.300 |
Why?
|
| Lipomatosis | 2 | 2018 | 112 | 0.290 |
Why?
|
| Hair Diseases | 1 | 2007 | 74 | 0.290 |
Why?
|
| Diazepam Binding Inhibitor | 1 | 2006 | 4 | 0.290 |
Why?
|
| Pregnancy Complications | 1 | 2021 | 2862 | 0.290 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2013 | 1341 | 0.290 |
Why?
|
| Biological Transport | 12 | 2016 | 2120 | 0.290 |
Why?
|
| Fever | 1 | 2014 | 1614 | 0.290 |
Why?
|
| Bone Plates | 1 | 2010 | 468 | 0.290 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2010 | 2942 | 0.280 |
Why?
|
| Gene Expression Regulation | 8 | 2021 | 12075 | 0.280 |
Why?
|
| Protein Biosynthesis | 4 | 2013 | 2126 | 0.280 |
Why?
|
| Bone Screws | 1 | 2010 | 520 | 0.280 |
Why?
|
| Sequence Alignment | 6 | 2013 | 2256 | 0.280 |
Why?
|
| Infant | 21 | 2022 | 35129 | 0.280 |
Why?
|
| Liver | 14 | 2018 | 7472 | 0.280 |
Why?
|
| Mice, Transgenic | 10 | 2020 | 9735 | 0.270 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2006 | 88 | 0.270 |
Why?
|
| Organizational Culture | 2 | 2012 | 510 | 0.270 |
Why?
|
| Coenzymes | 1 | 2006 | 91 | 0.270 |
Why?
|
| Substance-Related Disorders | 1 | 2022 | 4259 | 0.270 |
Why?
|
| Amino Acid Sequence | 16 | 2013 | 13817 | 0.270 |
Why?
|
| Chronic Disease | 2 | 2020 | 9147 | 0.270 |
Why?
|
| Anemia, Diamond-Blackfan | 2 | 2018 | 137 | 0.260 |
Why?
|
| RNA, Messenger | 14 | 2021 | 13036 | 0.260 |
Why?
|
| Hepatocytes | 6 | 2019 | 1210 | 0.260 |
Why?
|
| Infertility, Male | 4 | 2011 | 407 | 0.250 |
Why?
|
| Cell Cycle Proteins | 6 | 2015 | 3461 | 0.250 |
Why?
|
| Point Mutation | 4 | 2018 | 1624 | 0.250 |
Why?
|
| Neutropenia | 2 | 2021 | 895 | 0.240 |
Why?
|
| Syndrome | 6 | 2022 | 3250 | 0.240 |
Why?
|
| Ethylnitrosourea | 2 | 2015 | 51 | 0.240 |
Why?
|
| Endarterectomy, Carotid | 1 | 2009 | 546 | 0.240 |
Why?
|
| Endosomes | 5 | 2013 | 520 | 0.230 |
Why?
|
| Cilia | 1 | 2007 | 466 | 0.230 |
Why?
|
| Testosterone | 3 | 2020 | 2411 | 0.230 |
Why?
|
| Ticlopidine | 1 | 2009 | 899 | 0.230 |
Why?
|
| Pregnancy | 4 | 2022 | 29142 | 0.230 |
Why?
|
| Fracture Fixation, Internal | 1 | 2010 | 917 | 0.230 |
Why?
|
| Child, Preschool | 20 | 2022 | 40992 | 0.230 |
Why?
|
| Carotid Artery Diseases | 1 | 2009 | 882 | 0.220 |
Why?
|
| Cell Lineage | 3 | 2008 | 2504 | 0.220 |
Why?
|
| Cytosol | 1 | 2006 | 901 | 0.210 |
Why?
|
| Genes, Recessive | 1 | 2005 | 643 | 0.210 |
Why?
|
| Protein-Tyrosine Kinases | 4 | 2020 | 2455 | 0.210 |
Why?
|
| Cerebrovascular Disorders | 1 | 2009 | 1504 | 0.210 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2022 | 88 | 0.210 |
Why?
|
| Nuclear Receptor Coactivators | 2 | 2019 | 59 | 0.210 |
Why?
|
| Child | 30 | 2022 | 77679 | 0.210 |
Why?
|
| Visual Pathways | 1 | 2006 | 565 | 0.210 |
Why?
|
| Social Conditions | 1 | 2022 | 126 | 0.200 |
Why?
|
| Mitochondrial Myopathies | 1 | 2022 | 47 | 0.200 |
Why?
|
| Septins | 1 | 2021 | 54 | 0.200 |
Why?
|
| Nonheme Iron Proteins | 1 | 2021 | 9 | 0.200 |
Why?
|
| Adolescent | 25 | 2022 | 85759 | 0.200 |
Why?
|
| K562 Cells | 3 | 2020 | 634 | 0.200 |
Why?
|
| Erythroid Cells | 3 | 2020 | 238 | 0.200 |
Why?
|
| Genetic Association Studies | 4 | 2018 | 2702 | 0.200 |
Why?
|
| Zebrafish | 10 | 2022 | 2994 | 0.200 |
Why?
|
| GATA2 Transcription Factor | 1 | 2021 | 161 | 0.200 |
Why?
|
| Rats | 5 | 2013 | 24273 | 0.200 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2008 | 1692 | 0.190 |
Why?
|
| Crosses, Genetic | 4 | 2012 | 791 | 0.190 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2022 | 102 | 0.190 |
Why?
|
| Iron Metabolism Disorders | 1 | 2021 | 27 | 0.190 |
Why?
|
| Phosphoproteins | 4 | 2019 | 2440 | 0.190 |
Why?
|
| Megakaryocytes | 3 | 2019 | 545 | 0.190 |
Why?
|
| Hospital Administration | 1 | 2005 | 353 | 0.190 |
Why?
|
| Hemeproteins | 2 | 2013 | 62 | 0.190 |
Why?
|
| Bone Morphogenetic Proteins | 3 | 2013 | 838 | 0.190 |
Why?
|
| Hematopoietic Stem Cells | 5 | 2019 | 3385 | 0.190 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2023 | 314 | 0.190 |
Why?
|
| Autoimmune Lymphoproliferative Syndrome | 1 | 2020 | 13 | 0.190 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2010 | 2916 | 0.190 |
Why?
|
| Ferritins | 4 | 2021 | 590 | 0.190 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2015 | 4752 | 0.190 |
Why?
|
| Purines | 1 | 2024 | 594 | 0.190 |
Why?
|
| Chromosome Mapping | 6 | 2013 | 4742 | 0.180 |
Why?
|
| Arabs | 1 | 2022 | 178 | 0.180 |
Why?
|
| Osteoporosis | 1 | 2010 | 1580 | 0.180 |
Why?
|
| Middle Aged | 30 | 2022 | 213367 | 0.180 |
Why?
|
| Hematologic Diseases | 2 | 2022 | 498 | 0.180 |
Why?
|
| Megakaryocyte Progenitor Cells | 1 | 2019 | 22 | 0.180 |
Why?
|
| Prealbumin | 2 | 2012 | 210 | 0.180 |
Why?
|
| Receptors, Chemokine | 1 | 2003 | 669 | 0.180 |
Why?
|
| Young Adult | 16 | 2022 | 56436 | 0.180 |
Why?
|
| Splanchnic Circulation | 1 | 2020 | 110 | 0.180 |
Why?
|
| Blotting, Western | 9 | 2010 | 5180 | 0.180 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 2019 | 3523 | 0.180 |
Why?
|
| Chromosome Duplication | 1 | 2019 | 75 | 0.170 |
Why?
|
| Israel | 1 | 2022 | 796 | 0.170 |
Why?
|
| Blood Platelets | 3 | 2019 | 2508 | 0.170 |
Why?
|
| Bone Marrow Transplantation | 4 | 2020 | 2763 | 0.170 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2020 | 97 | 0.170 |
Why?
|
| Iron, Dietary | 3 | 2012 | 141 | 0.170 |
Why?
|
| Blood Coagulation Disorders, Inherited | 1 | 2019 | 18 | 0.170 |
Why?
|
| RNA Splicing | 2 | 2021 | 907 | 0.170 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2011 | 503 | 0.170 |
Why?
|
| Malabsorption Syndromes | 1 | 1999 | 135 | 0.170 |
Why?
|
| Parturition | 1 | 2022 | 441 | 0.170 |
Why?
|
| Genetic Linkage | 4 | 2015 | 2422 | 0.170 |
Why?
|
| Gene Deletion | 3 | 2019 | 2751 | 0.160 |
Why?
|
| Hydro-Lyases | 2 | 2016 | 94 | 0.160 |
Why?
|
| Acetylgalactosamine | 1 | 2018 | 37 | 0.160 |
Why?
|
| Granulocytes | 3 | 2010 | 547 | 0.160 |
Why?
|
| Blood Platelet Disorders | 1 | 2019 | 58 | 0.160 |
Why?
|
| Spleen | 6 | 2013 | 2361 | 0.160 |
Why?
|
| Fatty Acids | 1 | 2006 | 1808 | 0.160 |
Why?
|
| Fetus | 3 | 2016 | 1880 | 0.160 |
Why?
|
| Hospitals | 1 | 2012 | 3952 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2019 | 355 | 0.160 |
Why?
|
| Signal Recognition Particle | 1 | 2017 | 43 | 0.160 |
Why?
|
| Attitude of Health Personnel | 1 | 2012 | 3842 | 0.160 |
Why?
|
| Fractures, Bone | 1 | 2010 | 1947 | 0.150 |
Why?
|
| Telomerase | 4 | 2016 | 729 | 0.150 |
Why?
|
| Inflammasomes | 1 | 2022 | 494 | 0.150 |
Why?
|
| Receptors, Immunologic | 2 | 2018 | 1423 | 0.150 |
Why?
|
| Cell Membrane | 2 | 2012 | 3748 | 0.150 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 2 | 2014 | 52 | 0.150 |
Why?
|
| RNA, Small Interfering | 4 | 2015 | 3505 | 0.150 |
Why?
|
| B-Lymphocytes | 5 | 2019 | 4665 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 1 | 2010 | 4465 | 0.150 |
Why?
|
| Vascular Patency | 1 | 2020 | 886 | 0.150 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2013 | 2839 | 0.150 |
Why?
|
| Folic Acid | 1 | 2024 | 1300 | 0.150 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2022 | 1157 | 0.150 |
Why?
|
| Health Services | 1 | 2022 | 758 | 0.140 |
Why?
|
| Housing | 1 | 2021 | 664 | 0.140 |
Why?
|
| Bone Marrow | 5 | 2023 | 2944 | 0.140 |
Why?
|
| Cell Line | 10 | 2024 | 15999 | 0.140 |
Why?
|
| Immunohistochemistry | 11 | 2014 | 11368 | 0.140 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2009 | 3068 | 0.140 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2019 | 345 | 0.140 |
Why?
|
| Bone Marrow Cells | 3 | 2016 | 2513 | 0.140 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2017 | 195 | 0.140 |
Why?
|
| Liver Diseases | 2 | 2010 | 1254 | 0.140 |
Why?
|
| Kinetics | 5 | 2016 | 6474 | 0.140 |
Why?
|
| Spliceosomes | 1 | 2016 | 110 | 0.140 |
Why?
|
| Primary Myelofibrosis | 1 | 2018 | 215 | 0.140 |
Why?
|
| Adult | 33 | 2022 | 214035 | 0.140 |
Why?
|
| Molecular Chaperones | 1 | 2020 | 742 | 0.130 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2019 | 548 | 0.130 |
Why?
|
| Retina | 1 | 2006 | 2616 | 0.130 |
Why?
|
| Infant, Newborn | 8 | 2021 | 25618 | 0.130 |
Why?
|
| Cyclin A2 | 1 | 2015 | 21 | 0.130 |
Why?
|
| Cells, Cultured | 12 | 2021 | 19227 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 3 | 2011 | 6386 | 0.130 |
Why?
|
| Ribosomal Proteins | 1 | 2017 | 360 | 0.130 |
Why?
|
| HEK293 Cells | 5 | 2017 | 4201 | 0.130 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2019 | 871 | 0.130 |
Why?
|
| Immunosuppressive Agents | 2 | 2020 | 4151 | 0.130 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 2 | 2010 | 97 | 0.120 |
Why?
|
| Thrombectomy | 1 | 2020 | 679 | 0.120 |
Why?
|
| High-Throughput Screening Assays | 2 | 2011 | 945 | 0.120 |
Why?
|
| Hemorrhage | 1 | 2007 | 3461 | 0.120 |
Why?
|
| Trophoblasts | 1 | 2016 | 215 | 0.120 |
Why?
|
| RNA | 2 | 2016 | 2749 | 0.120 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2023 | 5442 | 0.120 |
Why?
|
| Mutagens | 1 | 2015 | 168 | 0.120 |
Why?
|
| Duodenum | 4 | 2013 | 483 | 0.120 |
Why?
|
| Antigens, CD | 2 | 2015 | 4026 | 0.120 |
Why?
|
| Mutagenesis | 3 | 2015 | 1267 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 5 | 2013 | 3846 | 0.120 |
Why?
|
| Anemia, Hemolytic, Congenital | 1 | 2014 | 69 | 0.120 |
Why?
|
| Genistein | 1 | 2014 | 84 | 0.120 |
Why?
|
| Glucuronosyltransferase | 1 | 2014 | 128 | 0.120 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2016 | 455 | 0.120 |
Why?
|
| Antigens, Nuclear | 1 | 2014 | 192 | 0.120 |
Why?
|
| Sirtuin 3 | 1 | 2014 | 68 | 0.120 |
Why?
|
| Hydrops Fetalis | 1 | 2014 | 107 | 0.120 |
Why?
|
| Genome | 2 | 2015 | 1808 | 0.120 |
Why?
|
| Bone Marrow Neoplasms | 1 | 2014 | 104 | 0.120 |
Why?
|
| Flavins | 1 | 2013 | 17 | 0.120 |
Why?
|
| Hemolysis | 3 | 2019 | 420 | 0.120 |
Why?
|
| Cytokinesis | 1 | 2015 | 177 | 0.110 |
Why?
|
| Erythropoietin | 5 | 2016 | 724 | 0.110 |
Why?
|
| Neoplasms, Experimental | 1 | 2019 | 1275 | 0.110 |
Why?
|
| Heterozygote | 5 | 2019 | 2805 | 0.110 |
Why?
|
| Erythrocyte Aging | 1 | 2012 | 52 | 0.110 |
Why?
|
| Cell Proliferation | 7 | 2019 | 10480 | 0.110 |
Why?
|
| Vulnerable Populations | 1 | 2018 | 686 | 0.110 |
Why?
|
| eIF-2 Kinase | 2 | 2005 | 150 | 0.110 |
Why?
|
| Mice, Inbred Strains | 3 | 2012 | 1827 | 0.110 |
Why?
|
| beta 2-Microglobulin | 2 | 2012 | 315 | 0.110 |
Why?
|
| DNA Primers | 2 | 2010 | 2892 | 0.110 |
Why?
|
| Tissue Distribution | 4 | 2007 | 2335 | 0.110 |
Why?
|
| Familial Mediterranean Fever | 1 | 2013 | 61 | 0.110 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2015 | 223 | 0.110 |
Why?
|
| Skin | 1 | 2006 | 4363 | 0.110 |
Why?
|
| Signal Transduction | 11 | 2019 | 23404 | 0.110 |
Why?
|
| Receptors, Androgen | 1 | 2019 | 1057 | 0.110 |
Why?
|
| Ubiquitination | 1 | 2017 | 1011 | 0.110 |
Why?
|
| Muscular Diseases | 2 | 2014 | 557 | 0.110 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2013 | 182 | 0.110 |
Why?
|
| Nova Scotia | 1 | 2012 | 34 | 0.110 |
Why?
|
| Mohs Surgery | 1 | 1995 | 197 | 0.110 |
Why?
|
| Inbreeding | 1 | 2012 | 49 | 0.110 |
Why?
|
| Zebrafish Proteins | 2 | 2009 | 1004 | 0.110 |
Why?
|
| Nanoparticles | 2 | 2015 | 1905 | 0.110 |
Why?
|
| Erythrocytes, Abnormal | 2 | 2016 | 125 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 7179 | 0.100 |
Why?
|
| Iron-Regulatory Proteins | 1 | 2012 | 32 | 0.100 |
Why?
|
| Continuity of Patient Care | 1 | 2019 | 1049 | 0.100 |
Why?
|
| Politics | 1 | 2018 | 791 | 0.100 |
Why?
|
| Genes, Synthetic | 1 | 2012 | 90 | 0.100 |
Why?
|
| Lower Extremity | 1 | 2020 | 1158 | 0.100 |
Why?
|
| Europe | 2 | 2020 | 3339 | 0.100 |
Why?
|
| Androgen Receptor Antagonists | 1 | 2012 | 114 | 0.100 |
Why?
|
| Phagosomes | 1 | 2013 | 193 | 0.100 |
Why?
|
| Telomere | 2 | 2016 | 910 | 0.100 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2021 | 2948 | 0.100 |
Why?
|
| Vitamin B 6 Deficiency | 1 | 2010 | 17 | 0.100 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2011 | 96 | 0.100 |
Why?
|
| Ciliary Motility Disorders | 1 | 2011 | 47 | 0.100 |
Why?
|
| Muscles | 1 | 2016 | 1622 | 0.100 |
Why?
|
| Genes, ras | 3 | 2010 | 690 | 0.100 |
Why?
|
| Phenylthiohydantoin | 1 | 2012 | 192 | 0.100 |
Why?
|
| Activin Receptors, Type I | 1 | 2011 | 142 | 0.100 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2019 | 1581 | 0.090 |
Why?
|
| Ischemia | 1 | 2020 | 1914 | 0.090 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2014 | 526 | 0.090 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2019 | 1873 | 0.090 |
Why?
|
| Aged | 15 | 2020 | 163253 | 0.090 |
Why?
|
| Combined Modality Therapy | 3 | 2020 | 8628 | 0.090 |
Why?
|
| Leukemia | 1 | 2019 | 1508 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2020 | 15525 | 0.090 |
Why?
|
| Drug Carriers | 1 | 2015 | 693 | 0.090 |
Why?
|
| Ion Transport | 3 | 2006 | 320 | 0.090 |
Why?
|
| Macrophages | 4 | 2013 | 5657 | 0.090 |
Why?
|
| Binding Sites | 4 | 2013 | 6116 | 0.090 |
Why?
|
| Protoporphyrins | 3 | 2005 | 164 | 0.090 |
Why?
|
| Bone and Bones | 1 | 2001 | 2575 | 0.090 |
Why?
|
| Autistic Disorder | 1 | 2019 | 1185 | 0.090 |
Why?
|
| Recurrence | 2 | 2020 | 8343 | 0.090 |
Why?
|
| Hemoglobins | 4 | 2016 | 1533 | 0.090 |
Why?
|
| Retrospective Studies | 10 | 2022 | 77426 | 0.090 |
Why?
|
| Patient Selection | 2 | 2020 | 4216 | 0.090 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2010 | 122 | 0.090 |
Why?
|
| Hematologic Tests | 1 | 2010 | 240 | 0.090 |
Why?
|
| Fetal Blood | 1 | 2016 | 1317 | 0.090 |
Why?
|
| Gene Expression | 5 | 2020 | 7799 | 0.090 |
Why?
|
| Splenomegaly | 2 | 2001 | 190 | 0.090 |
Why?
|
| Prognosis | 7 | 2020 | 29050 | 0.090 |
Why?
|
| Coronary Artery Disease | 1 | 2009 | 6489 | 0.090 |
Why?
|
| Genetic Testing | 3 | 2018 | 3443 | 0.090 |
Why?
|
| Smad Proteins | 1 | 2010 | 162 | 0.090 |
Why?
|
| Ion Channels | 1 | 2014 | 1056 | 0.090 |
Why?
|
| Models, Molecular | 3 | 2017 | 5458 | 0.090 |
Why?
|
| Carcinoma, Basal Cell | 1 | 1995 | 545 | 0.090 |
Why?
|
| Flow Cytometry | 5 | 2014 | 5974 | 0.080 |
Why?
|
| Chromosome Banding | 1 | 2008 | 278 | 0.080 |
Why?
|
| Peripheral Arterial Disease | 1 | 2020 | 1188 | 0.080 |
Why?
|
| Oncogene Proteins | 2 | 2015 | 749 | 0.080 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2010 | 1519 | 0.080 |
Why?
|
| Frameshift Mutation | 2 | 2020 | 399 | 0.080 |
Why?
|
| Cloning, Molecular | 7 | 2001 | 4321 | 0.080 |
Why?
|
| Alternative Splicing | 2 | 2019 | 1118 | 0.080 |
Why?
|
| Immunoenzyme Techniques | 2 | 2010 | 1799 | 0.080 |
Why?
|
| Fibroblasts | 4 | 2015 | 4156 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2022 | 4289 | 0.080 |
Why?
|
| Retroviridae | 3 | 2005 | 914 | 0.080 |
Why?
|
| Family Health | 2 | 2004 | 1282 | 0.080 |
Why?
|
| Ependyma | 1 | 2007 | 54 | 0.080 |
Why?
|
| Elasticity | 1 | 2010 | 657 | 0.080 |
Why?
|
| HLA-D Antigens | 1 | 2008 | 134 | 0.080 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2010 | 233 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 4 | 2020 | 5867 | 0.080 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2019 | 1596 | 0.080 |
Why?
|
| Urinalysis | 1 | 2010 | 369 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2013 | 8426 | 0.080 |
Why?
|
| Epithelial Cells | 3 | 2007 | 3690 | 0.080 |
Why?
|
| Equipment Design | 2 | 2020 | 3582 | 0.070 |
Why?
|
| Ferrochelatase | 2 | 2020 | 46 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 3871 | 0.070 |
Why?
|
| Oxidation-Reduction | 3 | 2012 | 2187 | 0.070 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2011 | 469 | 0.070 |
Why?
|
| Administration, Oral | 1 | 2015 | 3913 | 0.070 |
Why?
|
| Phagocytosis | 1 | 2013 | 1538 | 0.070 |
Why?
|
| Intestinal Absorption | 3 | 2012 | 420 | 0.070 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 2007 | 1380 | 0.070 |
Why?
|
| Animals, Congenic | 1 | 2006 | 27 | 0.070 |
Why?
|
| Albinism | 1 | 2006 | 25 | 0.070 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2010 | 902 | 0.070 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2008 | 166 | 0.070 |
Why?
|
| Exons | 2 | 2010 | 2439 | 0.070 |
Why?
|
| Time Factors | 8 | 2020 | 40063 | 0.070 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 1114 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3921 | 0.070 |
Why?
|
| Polymorphism, Genetic | 2 | 2013 | 4328 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2010 | 1155 | 0.070 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2010 | 260 | 0.070 |
Why?
|
| Antioxidants | 2 | 2004 | 1663 | 0.070 |
Why?
|
| Education, Medical, Continuing | 1 | 2012 | 840 | 0.070 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2007 | 249 | 0.070 |
Why?
|
| Materials Testing | 1 | 2010 | 867 | 0.070 |
Why?
|
| Iron Regulatory Protein 2 | 1 | 2006 | 41 | 0.070 |
Why?
|
| Immunologic Surveillance | 1 | 2006 | 93 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2012 | 3772 | 0.070 |
Why?
|
| Pyruvate Kinase | 1 | 2008 | 189 | 0.070 |
Why?
|
| Genetic Heterogeneity | 1 | 2010 | 733 | 0.070 |
Why?
|
| Aged, 80 and over | 7 | 2020 | 57768 | 0.070 |
Why?
|
| Integrases | 1 | 2008 | 533 | 0.070 |
Why?
|
| Treatment Outcome | 8 | 2020 | 63119 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2016 | 4553 | 0.070 |
Why?
|
| Gene Amplification | 1 | 2010 | 1062 | 0.070 |
Why?
|
| Gene Expression Regulation, Leukemic | 3 | 2019 | 651 | 0.070 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2002 | 1097 | 0.070 |
Why?
|
| Disclosure | 1 | 2012 | 736 | 0.070 |
Why?
|
| Ribosomes | 2 | 2021 | 500 | 0.070 |
Why?
|
| Microcephaly | 1 | 2010 | 432 | 0.070 |
Why?
|
| Boronic Acids | 1 | 2010 | 965 | 0.070 |
Why?
|
| Stem Cells | 2 | 2010 | 3567 | 0.070 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 5396 | 0.070 |
Why?
|
| Spherocytes | 1 | 2005 | 9 | 0.070 |
Why?
|
| Inflammation | 4 | 2016 | 10634 | 0.070 |
Why?
|
| Cytochrome b Group | 1 | 2005 | 60 | 0.070 |
Why?
|
| Antineoplastic Agents | 4 | 2019 | 13668 | 0.070 |
Why?
|
| Genes, Lethal | 1 | 2006 | 242 | 0.070 |
Why?
|
| Potassium Channels, Calcium-Activated | 1 | 2005 | 49 | 0.070 |
Why?
|
| Rats, Inbred F344 | 1 | 2006 | 862 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2010 | 1434 | 0.070 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 4 | 2013 | 1801 | 0.060 |
Why?
|
| Protein Binding | 3 | 2016 | 9392 | 0.060 |
Why?
|
| Oxidative Stress | 3 | 2005 | 3085 | 0.060 |
Why?
|
| Mice, Inbred C3H | 2 | 2015 | 964 | 0.060 |
Why?
|
| Interviews as Topic | 1 | 2012 | 2539 | 0.060 |
Why?
|
| Mitosis | 1 | 2010 | 1208 | 0.060 |
Why?
|
| Glycine | 2 | 1998 | 671 | 0.060 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 3023 | 0.060 |
Why?
|
| Receptor, Notch1 | 1 | 2008 | 502 | 0.060 |
Why?
|
| GTP-Binding Proteins | 2 | 2007 | 970 | 0.060 |
Why?
|
| Subcellular Fractions | 1 | 2005 | 547 | 0.060 |
Why?
|
| Protein Conformation | 1 | 2013 | 4012 | 0.060 |
Why?
|
| Blood Vessels | 1 | 2010 | 1126 | 0.060 |
Why?
|
| Failure to Thrive | 1 | 2005 | 136 | 0.060 |
Why?
|
| Stress, Mechanical | 1 | 2010 | 1686 | 0.060 |
Why?
|
| Embryonic Development | 1 | 2009 | 711 | 0.060 |
Why?
|
| Arginine | 2 | 1998 | 944 | 0.060 |
Why?
|
| Hematoma | 1 | 2009 | 758 | 0.060 |
Why?
|
| Embryo, Mammalian | 1 | 2010 | 1701 | 0.060 |
Why?
|
| Globins | 1 | 2005 | 415 | 0.060 |
Why?
|
| Immunophenotyping | 4 | 2014 | 1880 | 0.060 |
Why?
|
| Respiratory System | 1 | 2007 | 557 | 0.060 |
Why?
|
| Pyrazines | 1 | 2010 | 1231 | 0.060 |
Why?
|
| Cytoplasmic Granules | 1 | 2007 | 610 | 0.060 |
Why?
|
| Serine | 2 | 2006 | 828 | 0.060 |
Why?
|
| Lectins, C-Type | 1 | 2007 | 588 | 0.060 |
Why?
|
| Anemia, Hemolytic | 1 | 2005 | 168 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2020 | 23337 | 0.060 |
Why?
|
| Canada | 2 | 2011 | 2065 | 0.060 |
Why?
|
| Cholera Toxin | 1 | 2006 | 556 | 0.060 |
Why?
|
| Quinazolines | 1 | 2010 | 1356 | 0.060 |
Why?
|
| Anemia, Megaloblastic | 1 | 2003 | 25 | 0.060 |
Why?
|
| Erythrocyte Count | 2 | 2020 | 163 | 0.060 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2007 | 544 | 0.060 |
Why?
|
| Ischemic Attack, Transient | 1 | 2009 | 934 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2010 | 2503 | 0.060 |
Why?
|
| Risk Factors | 5 | 2021 | 72280 | 0.060 |
Why?
|
| Neurogenesis | 1 | 2010 | 838 | 0.060 |
Why?
|
| RNA-Binding Proteins | 2 | 2010 | 1903 | 0.060 |
Why?
|
| Transplantation Conditioning | 1 | 2010 | 1598 | 0.060 |
Why?
|
| Lymphocyte Activation | 1 | 2014 | 5523 | 0.060 |
Why?
|
| United States | 4 | 2020 | 69867 | 0.060 |
Why?
|
| Leptin | 1 | 2011 | 1599 | 0.060 |
Why?
|
| Disease Management | 1 | 2014 | 2458 | 0.060 |
Why?
|
| PPAR gamma | 1 | 2006 | 493 | 0.060 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2003 | 122 | 0.060 |
Why?
|
| Chemokine CCL20 | 1 | 2003 | 64 | 0.060 |
Why?
|
| Transduction, Genetic | 2 | 2005 | 913 | 0.060 |
Why?
|
| Receptors, CCR7 | 1 | 2003 | 108 | 0.060 |
Why?
|
| Anemia, Refractory | 1 | 2002 | 17 | 0.050 |
Why?
|
| Codon, Nonsense | 1 | 2004 | 281 | 0.050 |
Why?
|
| Receptors, CCR6 | 1 | 2003 | 81 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 7659 | 0.050 |
Why?
|
| Oxygen | 2 | 2013 | 4187 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2007 | 2007 | 0.050 |
Why?
|
| Pancreas | 2 | 2023 | 1686 | 0.050 |
Why?
|
| Blotting, Northern | 2 | 2001 | 1581 | 0.050 |
Why?
|
| Adenoma, Liver Cell | 1 | 2002 | 33 | 0.050 |
Why?
|
| Apoptosis | 7 | 2013 | 9728 | 0.050 |
Why?
|
| X Chromosome | 1 | 2006 | 815 | 0.050 |
Why?
|
| DNA-Binding Proteins | 6 | 2016 | 9647 | 0.050 |
Why?
|
| Tetraploidy | 1 | 2021 | 29 | 0.050 |
Why?
|
| Chromosome Inversion | 1 | 2002 | 127 | 0.050 |
Why?
|
| Heparin | 1 | 2009 | 1637 | 0.050 |
Why?
|
| DNA, Intergenic | 1 | 2022 | 107 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2014 | 2525 | 0.050 |
Why?
|
| Gene Targeting | 1 | 2005 | 880 | 0.050 |
Why?
|
| Pandemics | 1 | 2022 | 8387 | 0.050 |
Why?
|
| Trans-Activators | 3 | 2001 | 2924 | 0.050 |
Why?
|
| Chemokines, CC | 1 | 2003 | 291 | 0.050 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2013 | 1736 | 0.050 |
Why?
|
| Leukopoiesis | 1 | 2001 | 56 | 0.050 |
Why?
|
| Genomics | 2 | 2014 | 5722 | 0.050 |
Why?
|
| Pediatrics | 2 | 2011 | 3469 | 0.050 |
Why?
|
| Superoxide Dismutase | 1 | 2004 | 596 | 0.050 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2008 | 852 | 0.050 |
Why?
|
| Diagnosis, Differential | 5 | 2015 | 12961 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2006 | 1086 | 0.050 |
Why?
|
| Guideline Adherence | 1 | 2012 | 2266 | 0.050 |
Why?
|
| National Health Programs | 1 | 2005 | 445 | 0.050 |
Why?
|
| Genes, RAG-1 | 1 | 2001 | 68 | 0.050 |
Why?
|
| Milk Proteins | 1 | 2001 | 169 | 0.050 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2006 | 1039 | 0.050 |
Why?
|
| Penicillium chrysogenum | 2 | 1990 | 7 | 0.050 |
Why?
|
| Monocytes | 1 | 2010 | 2594 | 0.050 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2021 | 92 | 0.050 |
Why?
|
| Aspergillus nidulans | 2 | 1990 | 10 | 0.050 |
Why?
|
| Physical Chromosome Mapping | 1 | 2001 | 183 | 0.050 |
Why?
|
| Peroxidase | 2 | 2001 | 611 | 0.050 |
Why?
|
| DNA, Complementary | 2 | 2001 | 2050 | 0.050 |
Why?
|
| Social Work | 1 | 2022 | 162 | 0.050 |
Why?
|
| T-Lymphocytes | 3 | 2014 | 10182 | 0.050 |
Why?
|
| Open Reading Frames | 2 | 2001 | 810 | 0.050 |
Why?
|
| Guidelines as Topic | 2 | 2005 | 1404 | 0.050 |
Why?
|
| Cell Line, Tumor | 6 | 2014 | 16687 | 0.050 |
Why?
|
| Rhabdoid Tumor | 1 | 2002 | 212 | 0.050 |
Why?
|
| Receptor, erbB-2 | 1 | 2010 | 2416 | 0.050 |
Why?
|
| Phosphorylation | 6 | 2013 | 8437 | 0.050 |
Why?
|
| Cell Size | 2 | 2015 | 643 | 0.050 |
Why?
|
| Case Management | 1 | 2022 | 286 | 0.050 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2010 | 2041 | 0.050 |
Why?
|
| Lymphoma, T-Cell | 1 | 2002 | 299 | 0.050 |
Why?
|
| Protein Isoforms | 3 | 2019 | 1731 | 0.050 |
Why?
|
| Models, Biological | 4 | 2010 | 9582 | 0.040 |
Why?
|
| Chemotaxis | 1 | 2003 | 607 | 0.040 |
Why?
|
| Testis | 1 | 2003 | 800 | 0.040 |
Why?
|
| Absorption | 2 | 2013 | 248 | 0.040 |
Why?
|
| Aging | 2 | 2019 | 8661 | 0.040 |
Why?
|
| HIV Infections | 2 | 2019 | 16718 | 0.040 |
Why?
|
| Thrombocytosis | 1 | 2019 | 81 | 0.040 |
Why?
|
| Functional Laterality | 1 | 2006 | 2290 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2019 | 5529 | 0.040 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2001 | 434 | 0.040 |
Why?
|
| Penicillin-Binding Proteins | 2 | 1990 | 137 | 0.040 |
Why?
|
| Rats, Mutant Strains | 1 | 1998 | 70 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2008 | 1420 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1995 | 4033 | 0.040 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 1999 | 93 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11493 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2010 | 2727 | 0.040 |
Why?
|
| Washington | 1 | 2019 | 313 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 1998 | 1724 | 0.040 |
Why?
|
| Keratinocytes | 1 | 2003 | 798 | 0.040 |
Why?
|
| Cohort Studies | 6 | 2022 | 40559 | 0.040 |
Why?
|
| Receptors, Erythropoietin | 3 | 2005 | 147 | 0.040 |
Why?
|
| Genetic Complementation Test | 2 | 2012 | 562 | 0.040 |
Why?
|
| Neuroblastoma | 1 | 2006 | 1226 | 0.040 |
Why?
|
| Interleukin-1 | 1 | 2022 | 1263 | 0.040 |
Why?
|
| Suction | 1 | 2020 | 267 | 0.040 |
Why?
|
| Membrane Glycoproteins | 2 | 2007 | 3769 | 0.040 |
Why?
|
| Acyltransferases | 2 | 1990 | 294 | 0.040 |
Why?
|
| Triglycerides | 1 | 2006 | 2453 | 0.040 |
Why?
|
| Genetic Variation | 2 | 2011 | 6546 | 0.040 |
Why?
|
| Consanguinity | 1 | 2020 | 456 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2022 | 8321 | 0.040 |
Why?
|
| Chemokine CCL5 | 1 | 2019 | 209 | 0.040 |
Why?
|
| Linkage Disequilibrium | 2 | 2015 | 1997 | 0.040 |
Why?
|
| Bronchi | 1 | 2002 | 840 | 0.040 |
Why?
|
| Down-Regulation | 3 | 2013 | 3001 | 0.040 |
Why?
|
| CpG Islands | 1 | 2022 | 1172 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2019 | 386 | 0.040 |
Why?
|
| DNA Damage | 3 | 2019 | 2432 | 0.040 |
Why?
|
| Biopsy | 2 | 2014 | 6757 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2013 | 2557 | 0.040 |
Why?
|
| Survival Rate | 4 | 2019 | 12781 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 3 | 2019 | 6313 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2017 | 1337 | 0.040 |
Why?
|
| Lymphoma, B-Cell | 1 | 2004 | 931 | 0.040 |
Why?
|
| Pancreas, Exocrine | 1 | 2017 | 45 | 0.040 |
Why?
|
| Gene Rearrangement | 3 | 2014 | 1179 | 0.040 |
Why?
|
| Trust | 1 | 2022 | 505 | 0.040 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2010 | 625 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1998 | 323 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2006 | 6367 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2019 | 17449 | 0.040 |
Why?
|
| Cancer Vaccines | 1 | 2005 | 1024 | 0.040 |
Why?
|
| Osteoblasts | 1 | 2003 | 1165 | 0.040 |
Why?
|
| Autophagy | 2 | 2019 | 1300 | 0.040 |
Why?
|
| Limb Salvage | 1 | 2020 | 433 | 0.040 |
Why?
|
| HLA Antigens | 2 | 2001 | 1382 | 0.040 |
Why?
|
| Neoplasms | 4 | 2010 | 21672 | 0.040 |
Why?
|
| Kidney | 4 | 2008 | 7183 | 0.040 |
Why?
|
| Immunoassay | 2 | 2011 | 752 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 1 | 2018 | 418 | 0.040 |
Why?
|
| beta-Globins | 1 | 2017 | 113 | 0.040 |
Why?
|
| Spermatogenesis | 2 | 2011 | 262 | 0.040 |
Why?
|
| Chromosome Disorders | 1 | 2019 | 515 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 3 | 2009 | 894 | 0.040 |
Why?
|
| Bone Marrow Examination | 1 | 2016 | 157 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2014 | 5257 | 0.040 |
Why?
|
| Immunity, Humoral | 1 | 2021 | 598 | 0.040 |
Why?
|
| Mice, Inbred DBA | 1 | 1997 | 642 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2012 | 4687 | 0.030 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2019 | 294 | 0.030 |
Why?
|
| Potassium | 3 | 2005 | 1336 | 0.030 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2005 | 1269 | 0.030 |
Why?
|
| Pancreatic Diseases | 1 | 2018 | 350 | 0.030 |
Why?
|
| Codon | 1 | 1998 | 611 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2021 | 1420 | 0.030 |
Why?
|
| Genes, p53 | 1 | 1998 | 755 | 0.030 |
Why?
|
| Transcription Factors | 4 | 2019 | 12207 | 0.030 |
Why?
|
| Thigh | 1 | 1997 | 247 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 1655 | 0.030 |
Why?
|
| Breast Neoplasms | 3 | 2002 | 20817 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 1995 | 5670 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2020 | 712 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 2016 | 719 | 0.030 |
Why?
|
| Microsatellite Repeats | 1 | 1997 | 802 | 0.030 |
Why?
|
| Osmotic Fragility | 1 | 2014 | 37 | 0.030 |
Why?
|
| Sports | 1 | 2001 | 688 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2019 | 1401 | 0.030 |
Why?
|
| Hemangiosarcoma | 1 | 1997 | 239 | 0.030 |
Why?
|
| Dioxygenases | 1 | 2016 | 316 | 0.030 |
Why?
|
| Genomic Instability | 1 | 2019 | 695 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2019 | 671 | 0.030 |
Why?
|
| Karyotyping | 3 | 2002 | 1243 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2016 | 713 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2006 | 3703 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2009 | 4599 | 0.030 |
Why?
|
| Models, Genetic | 2 | 2002 | 3494 | 0.030 |
Why?
|
| Mice, Nude | 2 | 2013 | 3689 | 0.030 |
Why?
|
| Physician's Role | 1 | 2001 | 942 | 0.030 |
Why?
|
| Adult Children | 1 | 2014 | 100 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2010 | 2649 | 0.030 |
Why?
|
| Adenine | 1 | 2019 | 936 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2022 | 2682 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2019 | 1355 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2019 | 2726 | 0.030 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2013 | 56 | 0.030 |
Why?
|
| Cell Survival | 3 | 2013 | 5881 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2016 | 914 | 0.030 |
Why?
|
| Disease Progression | 3 | 2019 | 13280 | 0.030 |
Why?
|
| Survival Analysis | 3 | 2015 | 10250 | 0.030 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2013 | 60 | 0.030 |
Why?
|
| Immunoglobulin Variable Region | 2 | 1991 | 421 | 0.030 |
Why?
|
| Androgens | 1 | 2020 | 1279 | 0.030 |
Why?
|
| Gene Library | 2 | 2008 | 1076 | 0.030 |
Why?
|
| Lymphoma | 1 | 2002 | 1873 | 0.030 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 39045 | 0.030 |
Why?
|
| Eukaryotic Initiation Factor-2 | 2 | 2005 | 190 | 0.030 |
Why?
|
| Biology | 1 | 1994 | 294 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2019 | 1814 | 0.030 |
Why?
|
| Siblings | 1 | 2016 | 854 | 0.030 |
Why?
|
| Polycythemia | 1 | 2013 | 126 | 0.030 |
Why?
|
| Intracellular Membranes | 1 | 2013 | 390 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 2915 | 0.030 |
Why?
|
| Spermatids | 1 | 2011 | 36 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2008 | 3747 | 0.030 |
Why?
|
| Chlorides | 2 | 2004 | 667 | 0.030 |
Why?
|
| Catalysis | 2 | 2004 | 761 | 0.030 |
Why?
|
| Breast | 1 | 2001 | 1969 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 1998 | 1782 | 0.030 |
Why?
|
| Thiamine | 2 | 2003 | 152 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 2 | 2013 | 2700 | 0.020 |
Why?
|
| Maxillary Sinusitis | 1 | 2011 | 39 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2001 | 2422 | 0.020 |
Why?
|
| Endocytosis | 1 | 2015 | 985 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2000 | 1939 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2012 | 198 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 1940 | 0.020 |
Why?
|
| Disease-Free Survival | 2 | 2012 | 6893 | 0.020 |
Why?
|
| Haplotypes | 1 | 1997 | 2781 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2019 | 2486 | 0.020 |
Why?
|
| Neurons | 1 | 2010 | 9335 | 0.020 |
Why?
|
| Swine | 1 | 2021 | 5940 | 0.020 |
Why?
|
| Cell Separation | 2 | 2010 | 1751 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2015 | 713 | 0.020 |
Why?
|
| Penicillium | 1 | 1990 | 22 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2019 | 2969 | 0.020 |
Why?
|
| Janus Kinase 2 | 2 | 2005 | 528 | 0.020 |
Why?
|
| Piperidines | 1 | 2019 | 1605 | 0.020 |
Why?
|
| Prevalence | 2 | 2021 | 15226 | 0.020 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2010 | 47 | 0.020 |
Why?
|
| Viral Load | 1 | 2019 | 3300 | 0.020 |
Why?
|
| Glutaredoxins | 1 | 2010 | 32 | 0.020 |
Why?
|
| Cell Aggregation | 1 | 2010 | 244 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5076 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 2020 | 2161 | 0.020 |
Why?
|
| Acyl Coenzyme A | 1 | 1990 | 55 | 0.020 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2010 | 110 | 0.020 |
Why?
|
| Lentivirus | 1 | 2013 | 501 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2012 | 466 | 0.020 |
Why?
|
| Cell Division | 3 | 2002 | 4567 | 0.020 |
Why?
|
| Perforin | 1 | 2010 | 168 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2022 | 53280 | 0.020 |
Why?
|
| Protein Transport | 2 | 2007 | 1989 | 0.020 |
Why?
|
| Epididymis | 1 | 2011 | 227 | 0.020 |
Why?
|
| Child Development | 1 | 2001 | 2223 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2010 | 323 | 0.020 |
Why?
|
| Medical Records | 1 | 2015 | 1413 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 3646 | 0.020 |
Why?
|
| Acute Disease | 1 | 2020 | 7148 | 0.020 |
Why?
|
| Genes, Fungal | 1 | 1990 | 455 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2014 | 1758 | 0.020 |
Why?
|
| Taxoids | 1 | 2012 | 665 | 0.020 |
Why?
|
| Proteomics | 2 | 2017 | 3637 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2011 | 390 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2013 | 1547 | 0.020 |
Why?
|
| Cell Cycle | 2 | 2009 | 2967 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 15070 | 0.020 |
Why?
|
| Fructosediphosphates | 1 | 2008 | 24 | 0.020 |
Why?
|
| Vaccination | 1 | 2021 | 3278 | 0.020 |
Why?
|
| Crystallography | 1 | 2008 | 111 | 0.020 |
Why?
|
| Estradiol | 1 | 2016 | 2020 | 0.020 |
Why?
|
| Metalloporphyrins | 1 | 2008 | 41 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2019 | 1973 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2013 | 2012 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2015 | 3617 | 0.020 |
Why?
|
| Yeasts | 1 | 2009 | 285 | 0.020 |
Why?
|
| Lysosomes | 1 | 2013 | 893 | 0.020 |
Why?
|
| Health Personnel | 1 | 2021 | 3216 | 0.020 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2008 | 106 | 0.020 |
Why?
|
| Histiocytosis, Sinus | 1 | 2008 | 47 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2011 | 427 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 2010 | 11007 | 0.020 |
Why?
|
| Reference Standards | 1 | 2011 | 1025 | 0.020 |
Why?
|
| Base Pairing | 1 | 2008 | 143 | 0.020 |
Why?
|
| Stents | 1 | 2020 | 3280 | 0.020 |
Why?
|
| Static Electricity | 1 | 2008 | 267 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2010 | 4217 | 0.020 |
Why?
|
| Antigens, CD1 | 1 | 2010 | 437 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2012 | 12035 | 0.020 |
Why?
|
| NADP | 1 | 2008 | 226 | 0.020 |
Why?
|
| Nitriles | 1 | 2012 | 952 | 0.020 |
Why?
|
| Epitopes | 2 | 1991 | 2571 | 0.020 |
Why?
|
| Pyruvic Acid | 1 | 2008 | 200 | 0.020 |
Why?
|
| Spermatozoa | 1 | 2011 | 625 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2014 | 2216 | 0.020 |
Why?
|
| Blood Proteins | 1 | 1992 | 1123 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 1995 | 2914 | 0.020 |
Why?
|
| Chromosomes, Mammalian | 1 | 2007 | 151 | 0.020 |
Why?
|
| Benzamides | 1 | 2012 | 1378 | 0.020 |
Why?
|
| Stroke | 1 | 2009 | 9981 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2019 | 2940 | 0.020 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2013 | 770 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 3584 | 0.020 |
Why?
|
| Dimerization | 1 | 2008 | 893 | 0.020 |
Why?
|
| Hemin | 1 | 2006 | 49 | 0.020 |
Why?
|
| Fetal Diseases | 2 | 2001 | 903 | 0.020 |
Why?
|
| Endovascular Procedures | 1 | 2020 | 1979 | 0.020 |
Why?
|
| Fishes | 1 | 2009 | 569 | 0.020 |
Why?
|
| Mass Screening | 1 | 2021 | 5252 | 0.020 |
Why?
|
| Oxidative Phosphorylation | 1 | 2008 | 480 | 0.020 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2006 | 215 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 2505 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2005 | 1990 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2010 | 1549 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2010 | 1344 | 0.020 |
Why?
|
| Carrier State | 1 | 2009 | 518 | 0.020 |
Why?
|
| Clotrimazole | 1 | 2005 | 77 | 0.020 |
Why?
|
| Hydroxyethylrutoside | 1 | 2004 | 4 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2015 | 2575 | 0.020 |
Why?
|
| Trachea | 1 | 2011 | 1075 | 0.020 |
Why?
|
| Annexins | 1 | 2004 | 38 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2010 | 987 | 0.020 |
Why?
|
| Heat Stress Disorders | 1 | 2005 | 50 | 0.020 |
Why?
|
| Hydrocephalus | 1 | 2011 | 748 | 0.020 |
Why?
|
| Structure-Activity Relationship | 2 | 2001 | 3133 | 0.020 |
Why?
|
| Myeloid Cells | 1 | 2009 | 809 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2010 | 3701 | 0.020 |
Why?
|
| Stress, Physiological | 2 | 2001 | 1404 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2008 | 2085 | 0.010 |
Why?
|
| Glycolysis | 1 | 2008 | 826 | 0.010 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2005 | 246 | 0.010 |
Why?
|
| Genome-Wide Association Study | 2 | 2015 | 12264 | 0.010 |
Why?
|
| Erythrocyte Membrane | 1 | 2004 | 442 | 0.010 |
Why?
|
| Infrared Rays | 1 | 2004 | 249 | 0.010 |
Why?
|
| Superoxides | 1 | 2004 | 387 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 4803 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 2005 | 655 | 0.010 |
Why?
|
| Immunologic Memory | 1 | 1989 | 1348 | 0.010 |
Why?
|
| Lactic Acid | 1 | 2008 | 1132 | 0.010 |
Why?
|
| Neutrophils | 2 | 2008 | 3717 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 2013 | 1623 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 4929 | 0.010 |
Why?
|
| Glycogen Storage Disease Type I | 1 | 2002 | 53 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 5138 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 3614 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2011 | 19907 | 0.010 |
Why?
|
| Polyribosomes | 1 | 2001 | 110 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2010 | 4776 | 0.010 |
Why?
|
| Hematopoietic Cell Growth Factors | 1 | 2001 | 102 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2010 | 1838 | 0.010 |
Why?
|
| Simian virus 40 | 1 | 2002 | 295 | 0.010 |
Why?
|
| RNA Probes | 1 | 2001 | 113 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 4841 | 0.010 |
Why?
|
| Intestinal Mucosa | 2 | 2005 | 3036 | 0.010 |
Why?
|
| Anti-Retroviral Agents | 1 | 2011 | 1715 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6535 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2010 | 2501 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2008 | 1869 | 0.010 |
Why?
|
| Escherichia coli | 2 | 1990 | 4220 | 0.010 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 2001 | 189 | 0.010 |
Why?
|
| Sequence Homology | 1 | 2001 | 203 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 2005 | 973 | 0.010 |
Why?
|
| Socialization | 1 | 2001 | 87 | 0.010 |
Why?
|
| STAT5 Transcription Factor | 1 | 2001 | 259 | 0.010 |
Why?
|
| Physical Education and Training | 1 | 2001 | 106 | 0.010 |
Why?
|
| Penetrance | 1 | 2002 | 381 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2002 | 898 | 0.010 |
Why?
|
| Brain | 1 | 2007 | 26413 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 2004 | 731 | 0.010 |
Why?
|
| Chromosome Walking | 1 | 2000 | 27 | 0.010 |
Why?
|
| Mice, Inbred A | 2 | 1991 | 248 | 0.010 |
Why?
|
| Microvilli | 1 | 2000 | 241 | 0.010 |
Why?
|
| Hematocrit | 1 | 2001 | 636 | 0.010 |
Why?
|
| Vitamin E | 1 | 2004 | 869 | 0.010 |
Why?
|
| Electroporation | 1 | 2001 | 251 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 2001 | 411 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 2001 | 587 | 0.010 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2001 | 258 | 0.010 |
Why?
|
| Yolk Sac | 1 | 2000 | 75 | 0.010 |
Why?
|
| Homozygote | 1 | 2004 | 1786 | 0.010 |
Why?
|
| Fetal Death | 1 | 2001 | 447 | 0.010 |
Why?
|
| Seizures | 1 | 2012 | 2859 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1991 | 1086 | 0.010 |
Why?
|
| Linear Models | 1 | 2010 | 5953 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2004 | 1267 | 0.010 |
Why?
|
| Genes, Immunoglobulin | 2 | 1991 | 291 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 853 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 2002 | 769 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2005 | 1364 | 0.010 |
Why?
|
| Deafness | 1 | 2003 | 461 | 0.010 |
Why?
|
| Cricetulus | 1 | 2001 | 817 | 0.010 |
Why?
|
| Muridae | 1 | 1998 | 61 | 0.010 |
Why?
|
| Water | 1 | 2005 | 1395 | 0.010 |
Why?
|
| Genes, MHC Class I | 1 | 1999 | 258 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 12244 | 0.010 |
Why?
|
| Enterocytes | 1 | 2000 | 225 | 0.010 |
Why?
|
| Cell Movement | 1 | 2010 | 5216 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2005 | 1531 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2001 | 2645 | 0.010 |
Why?
|
| CHO Cells | 1 | 2001 | 1407 | 0.010 |
Why?
|
| Family | 1 | 2009 | 3148 | 0.010 |
Why?
|
| Motor Skills | 1 | 2001 | 522 | 0.010 |
Why?
|
| Xenopus | 1 | 2000 | 712 | 0.010 |
Why?
|
| Genetic Vectors | 2 | 2002 | 3420 | 0.010 |
Why?
|
| Veterans | 1 | 2011 | 2519 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2004 | 2025 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 2 | 2001 | 6172 | 0.010 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2002 | 736 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2000 | 1682 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2001 | 1950 | 0.010 |
Why?
|
| Cerebellum | 1 | 2004 | 1490 | 0.010 |
Why?
|
| Cricetinae | 1 | 2001 | 2472 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2002 | 2088 | 0.010 |
Why?
|
| Physical Fitness | 1 | 2001 | 733 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1995 | 9230 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2007 | 2725 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2003 | 1361 | 0.010 |
Why?
|
| Intestines | 1 | 2005 | 1924 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2010 | 6259 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2001 | 1152 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2001 | 1640 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2005 | 2938 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 1999 | 1137 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 14726 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1998 | 1246 | 0.010 |
Why?
|
| Models, Animal | 1 | 2001 | 2171 | 0.010 |
Why?
|
| Transfection | 1 | 2001 | 5892 | 0.010 |
Why?
|
| Mammals | 1 | 1999 | 1144 | 0.010 |
Why?
|
| Gestational Age | 1 | 2001 | 3493 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2010 | 12718 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2004 | 4559 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2001 | 2382 | 0.010 |
Why?
|
| Activating Transcription Factors | 1 | 1992 | 29 | 0.010 |
Why?
|
| Calcium | 1 | 2005 | 5757 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1998 | 1836 | 0.010 |
Why?
|
| Haptens | 1 | 1991 | 166 | 0.010 |
Why?
|
| Mammography | 1 | 2002 | 2477 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1991 | 427 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1991 | 803 | 0.010 |
Why?
|
| Glucose | 1 | 2002 | 4396 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 1990 | 263 | 0.010 |
Why?
|
| p-Azobenzenearsonate | 1 | 1989 | 41 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1990 | 878 | 0.010 |
Why?
|
| Genes, Switch | 1 | 1989 | 47 | 0.010 |
Why?
|
| Human Genome Project | 1 | 1990 | 192 | 0.010 |
Why?
|
| Azo Compounds | 1 | 1989 | 113 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2012 | 11074 | 0.010 |
Why?
|
| Immunoglobulin Isotypes | 1 | 1989 | 158 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1990 | 683 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 10949 | 0.010 |
Why?
|
| Lung | 1 | 2008 | 9852 | 0.010 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 1989 | 173 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 1992 | 880 | 0.010 |
Why?
|
| Benzenesulfonates | 1 | 1989 | 169 | 0.010 |
Why?
|
| Hybridomas | 1 | 1989 | 452 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2010 | 35423 | 0.000 |
Why?
|
| Tumor Suppressor Proteins | 1 | 1998 | 2848 | 0.000 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1999 | 2752 | 0.000 |
Why?
|
| Antibody Specificity | 1 | 1989 | 1095 | 0.000 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1989 | 659 | 0.000 |
Why?
|
| Endopeptidases | 1 | 1990 | 772 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1990 | 1574 | 0.000 |
Why?
|
| Clone Cells | 1 | 1989 | 1692 | 0.000 |
Why?
|
| Transcriptional Activation | 1 | 1992 | 1782 | 0.000 |
Why?
|
| Plasmids | 1 | 1990 | 2307 | 0.000 |
Why?
|
| Diabetes Mellitus | 1 | 2003 | 5755 | 0.000 |
Why?
|
| Age Factors | 1 | 2001 | 18367 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 2008 | 13096 | 0.000 |
Why?
|
| Recombinant Proteins | 1 | 1990 | 6612 | 0.000 |
Why?
|
| DNA | 1 | 1992 | 7303 | 0.000 |
Why?
|
| Databases, Factual | 1 | 1990 | 7730 | 0.000 |
Why?
|